Sagespring Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Buy
15,716
+198
+1% +$15.3K 0.02% 295
2025
Q4
$1.23M Buy
15,518
+679
+5% +$53.5K 0.02% 270
2025
Q3
$1.12M Buy
14,839
+104
+0.7% +$7.13K 0.02% 285
2025
Q2
$1.02M Buy
14,735
+1,994
+16% +$131K 0.02% 280
2025
Q1
$863K Buy
12,741
+5,980
+88% +$358K 0.02% 268
2024
Q4
$303K Buy
+6,761
New +$379K 0.01% 476

Other funds holding CVS

Sagespring Wealth Partners's CVS Position: Q1 2026 in Review

Sagespring Wealth Partners increased its CVS Health (CVS) stake by 1.3% in Q1 2026, buying an estimated $15.3K and bringing the position to 15,716 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #295.

Sagespring Wealth Partners first reported a position in CVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.23M in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Sagespring Wealth Partners held 15,716 shares of CVS Health worth $1.13M as of Q1 2026.
  • Sagespring Wealth Partners bought 198 CVS Health shares in Q1 2026, an estimated $15.3K.
  • CVS Health made up 0.02% of Sagespring Wealth Partners's portfolio in Q1 2026, its #295 holding.
  • Sagespring Wealth Partners first reported a position in CVS Health in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's CVS Health position peaked at $1.23M in Q4 2025.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.